This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's What Key Metrics Tell Us About Jefferies (JEF) Q4 Earnings
by Zacks Equity Research
The headline numbers for Jefferies (JEF) give insight into how the company performed in the quarter ended November 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Jefferies (JEF) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Jefferies (JEF) delivered earnings and revenue surprises of 7.14% and 6.55%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
Scotiabank to Transfer Latin American Banking Operations to Davivienda
by Zacks Equity Research
BNS agrees to transfer its Latin American banking arms to Davivienda for a roughly 20% stake. This aligns with the bank's efforts to boost efficiency.
Recent Price Trend in Jefferies (JEF) is Your Friend, Here's Why
by Zacks Equity Research
Jefferies (JEF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
IB & Trading to Aid Jefferies' Q4 Earnings, High Costs to Hurt
by Zacks Equity Research
Improvement in IB and trading business performance is likely to have aided JEF's fiscal Q4 earnings while rising expenses are expected to have hurt.
Jefferies (JEF) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Jefferies (JEF), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended November 2024.
Jefferies (JEF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Jefferies (JEF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sumitomo Mitsui Considers Expanding Collaboration With Jefferies
by Zacks Equity Research
SMFG plans to boost its partnership with JEF to explore new business areas such as equity trading and drive growth in the Asia-Pacific region.
Is First Trust Financials AlphaDEX ETF (FXO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXO
Jefferies Shares Hit All-Time High: Will the Uptrend Continue in 2025?
by Zacks Equity Research
JEF stock touches an all-time high of $82.04. Read on to know the driving factors and whether the stock is worth betting on for 2025.
Is Post-Election Rebound in U.S. IPOs Likely? ETFs in Focus
by Sanghamitra Saha
After two years of subdued IPO activity, the U.S. IPO market may be up for a revival during Trump presidency on the likelihood of an upbeat stock market.
Raymond James' Q4 Earnings Beat, Stock Up on Solid IB Business
by Zacks Equity Research
Robust IB business performance, higher revenues and improvement in assets under administration balance support RJF's fiscal Q4 earnings.
Is First Trust Financials AlphaDEX ETF (FXO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXO
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPME
Will JPM, C and Others Follow JEF and Post Solid Q3 IB Income?
by Swayta Shah
Jefferies post robust Q3 IB fee growth. Let's try to figure out how other banks, including JPMorgan, Citigroup, Bank of America and Goldman, will likely perform.
Blackstone Expects Profits From Exiting Deals to be Muted in Q3
by Zacks Equity Research
BX provides an intra-quarter realization update. It estimates revenues from realization activities in excess of $300 million from the start of Q3 till Sept. 24.
Jefferies' Q3 Earnings & Revenues Miss Estimates, Stock Slides 1.1%
by Zacks Equity Research
A rise in non-interest expenses hurt JEF's fiscal Q3 earnings. On the other hand, solid IB business performance offers support.
Compared to Estimates, Jefferies (JEF) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Jefferies (JEF) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Jefferies (JEF) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Jefferies (JEF) delivered earnings and revenue surprises of -6.25% and 2.25%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
Ahead of Jefferies (JEF) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Jefferies (JEF), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended August 2024.
Is SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KCE
Why Earnings Season Could Be Great for Jefferies Financial (JEF)
by Zacks Equity Research
Jefferies Financial (JEF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Jefferies (JEF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Jefferies (JEF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Makes Jefferies (JEF) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Jefferies (JEF) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Jefferies (JEF) Could Beat Earnings Estimates Again
by Zacks Equity Research
Jefferies (JEF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.